Effect of Alendronate with β – TCP Bone Substitute in Surgical Therapy of Periodontal Intra-Osseous Defects: A Randomized Controlled Clinical Trial

INTRODUCTION: Alendronate (ALN), an aminobisphosphonate, inhibits osteoclastic bone resorption and also stimulates osteogenesis. Beta-Tricalcium Phosphate (β-TCP) is an osteoconductive graft material which provides a scaffold for bone formation and also a widely used drug delivery vehicle for growth...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Diagn Res
Asıl Yazarlar: Naineni, Rohini, Ravi, Vishali, Subbaraya, Dwijendra Kocherlakota, Prasanna, Jammula Surya, Panthula, Veerendranath Reddy, Koduganti, Rekha Rani
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: JCDR Research and Publications (P) Limited 2016
Konular:
Dentistry Section
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5028499/
https://ncbi.nlm.nih.gov/pubmed/27656552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2016/20965.8365
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller